Recent APDN Stock Price | APDN Stock Predictions | |
$4.09 | +1000.24% |
$45.00 |
Recent APDN Analyst Ratings Breakdown, Making APDN Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 2 | 2 | 2 | 2 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the APDN stock predictions from the analysts covering Applied DNA Sciences Inc, we have collected all of the individual APDN stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 2 different analysts covering APDN (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since APDN stock predictions may vary widely, another useful metric to consider is the median APDN stock prediction, which represents the price at which half of the analysts
made APDN stock predictions that were higher and half made APDN stock predictions that were lower. This makes for a different take on the APDN stock predictions out there, as compared to average or mean.
And that median across all the individual APDN stock predictions was: $45.0 as of 2024-05-03.
The very highest of the APDN stock predictions for one year price target was $60.0, while the very lowest of the APDN stock predictions in the analyst group was
$30.0 (with a standard deviation of $21.213). Get the latest Zacks research report on APDN — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
OPTN Stock Predictions
PENN Stock Predictions
KEY Stock Predictions
GFL Stock Predictions
CHTR Stock Predictions
PCVX Stock Predictions
PAR Stock Predictions
HOG Stock Predictions
YTEN Stock Predictions
|
|
Strong Buy (4.00 out of 4) 99th percentile
(ranked higher than approx. 99% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |